Fund
Omega Funds
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 2
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 23 September 2026
- Sectors
- Medtech, Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 23 Sept | Spain, Medtech | Undisclosed | 56 M$ | Lead |
| 11 Aug | Switzerland, Biotech | Series B | 152 M$ | Participant |
| 13 Mar | United States, Biotech | Undisclosed | 197 M$ | Lead |
Co investors 18 funds crossed
- Andera Partners 1 operation
- Asabys Partners 1 operation
- Avego BioScience Capital 1 operation
- CDTI Innvierte 1 operation
- COFIDES 1 operation
- Droia Ventures 1 operation
- EQT Life Sciences 1 operation
- Jeito Capital 1 operation
- Kalehua Capital 1 operation
- Kurma Partners 1 operation
- Life Sciences at Goldman Sachs Alternatives 1 operation
- Medicxi 1 operation
- New Rhein Healthcare Investors 1 operation
- Novo Holdings 1 operation
- Perceptive Advisors 1 operation
- Sanofi Capital 1 operation
- TCGX 1 operation
- Ysios Capital 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Spain, Switzerland, United States.